Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The current status of cell‐free human papillomavirus DNA as a biomarker in cervical cancer and other HPV ‐associated tumors: A review

24 Oct 2022

Abstract excerpt

Tumor cells release fragments of their DNA into the circulation, so called cell-free tumor DNA (ctDNA), allowing for analysis of tumor DNA in a simple blood test, that is, liquid biopsy. Cervical cancer is one of the most common malignancies among women worldwide and high-risk human papillomavirus (HR-HPV) is the cause of the majority of cases. HR-HPV integrates into the host genome and is often present in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Cervical Cancer and HPV Research
Share to Genetic factors in colorectal cancer

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36274628
DOI: 10.1002/ijc.34333

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 24 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The current status of cell‐free human papillomavirus DNA as a biomarker in cervical cancer and other HPV ‐associated tumors: A reviewPMID 36274628Read ↗

Circulating cell-free tumor human papillomavirus DNA is a promising biomarker in cervical cancerSemantic proximity Read ↗

Detection of circulating cell-free HPV DNA of 13 HPV types for patients with cervical cancer as potential biomarker to monitor therapy response and to detect relapseSemantic proximity Read ↗

Prognostic value of circulating HPV cell-free DNA in cervical cancer using liquid biopsySemantic proximity Read ↗

Cell-Free HPV-DNA in Screening, Diagnosis, Prognosis, and Treatment Response Monitoring of Cervical CancerSemantic proximity Read ↗

Cell-Free Human Papillomavirus DNA Is a Sensitive Biomarker for Prognosis and for Early Detection of Relapse in Locally Advanced Cervical CancerSemantic proximity Read ↗

Molecular tests potentially improving HPV screening and genotyping for cervical cancer preventionSemantic proximity Read ↗

A NGS-based Blood Test For the Diagnosis of Invasive HPV-associated Carcinomas with Extensive Viral Genomic CharacterizationSemantic proximity Read ↗

Potential Biomarkers for Cervical Cancer Screening and TreatmentSemantic proximity Read ↗

Integrating non-coding RNA profiling with HPV genotyping for cervical cancer risk stratification and early detection.Semantic proximity Read ↗

Human papillomavirus DNA in plasma of patients with cervical cancerSemantic proximity Read ↗

Harnessing viral footprints in circulating free DNA ( cfDNA ) for early cancer detection: A focus on liquid‐biopsy‐based screeningSemantic proximity Read ↗

Digital droplet PCR-based quantification of ccfHPV-DNA as liquid biopsy in HPV-driven cervical and vulvar cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.